Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs
Go back to Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs| (NASDAQ: KZIA) | Delayed: 12.03 -0.66 (5.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.69 | 52 Week High | $ | |||
| Open | $12.64 | 52 Week Low | $ | |||
| Day High | $13.22 | P/E | N/A | |||
| Day Low | $11.78 | EPS | $ | |||
| Volume | 162,214 | |||||

